Trials / Completed
CompletedNCT00289367
Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Randomized Prospective Study of T3 on the Incidence of Post-Operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this project is to see whether treatment with a thyroid hormone, called triiodothyronine or T3, following open heart surgery reduces the risk of developing atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triiodothyronine | 0.8 mcg/kg bolus loading dose followed by a six hour infusion of 0.8 mcg/kg/6hr. |
| DRUG | triiodothyronine | IV formulation - Triostat, 0.8 mcg/kg bolus loading dose followed by a six hour infusion of 0.8 mcg/kg/6hr. |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2006-08-01
- Completion
- 2008-05-01
- First posted
- 2006-02-09
- Last updated
- 2008-05-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00289367. Inclusion in this directory is not an endorsement.